Similar Items: Successful Treatment of Refractory Chronic Spontaneous Urticaria with Stapokibart After Omalizumab Failure: A Case Report
- Analysis of Predictors of Response Degree to Omalizumab in 124 Patients with Chronic Spontaneous Urticaria
- The Impact of Chronic Spontaneous Urticaria on Sleep—A Systematic Review
- Review on the Application of Biologic Factors in Atopic Dermatitis and Chronic Spontaneous Urticaria
- Correction: Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study
- Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
- Successful Treatment of Refractory Lichen Amyloidosus With Dupilumab